Oral Session 1-7A Malignant Lymphoma: Clinical Trials

[OS1-7A-5] Randomized phase III study of biosimilar CT-P10 vs rituximab in untreated FL with low tumor burden

Michinori Ogura¹, Juan Manuel Sancho², Seok-Goo Cho³, Hideyuki Nakazawa⁴, Junji Suzumiya⁵, Gayane Tumyan⁶, Jin Seok Kim⁷, Anne Lennard⁸, Jose M. Mariz⁹, Nikolai Ilyin¹⁰, Wojciech Jurczak¹¹, Aurelio Lopez Martinez¹², Olga Samoilova¹³, Edvard Zhavrid¹⁴, Eduardo Yanez Ruiz¹⁵, Marek Trneny¹⁶, Leslie Popplewell¹⁷, Christian Buske¹⁸, Won Seog Kim¹⁹, SangJoon Lee²⁰, YunJu Bae²⁰, JeongAh Park²⁰, YeonMi Lee²⁰, SangEun Han²⁰, Larry W. Kwak²¹ (1.Department of Hematology and Oncology, Kasugai Municipal Hospital, Kasugai, Aichi, Japan, 2.Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain, 3.Department of Hematology, Leukemia Research Institute, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, 4.Department of Hematology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan, 5.Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, Izumo, Shimane, Japan, 6.Department of Chemotherapy of Hemoblastosis, Blokhin Russian Cancer Research Center, Moscow, Moscow, Russian Federation, 7.Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea, 8.Northern Institute for Cancer Care, Newcastle University, Newcastle upon Tyne, Tyne-Wear, United Kingdom of Great Britain and Northern Ireland, 9.Department of Hematology, Instituto Potugues de Oncologia, Porto, Portuguese Republic, 10.Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation, 11.Department of Haematology, Jagiellonian University, Krakow, Malopolskie, Republic of Poland, 12.Hospital Arnau de Vilanova, Valencia, Comunidad Valenciana, Spain, 13.Nizhny Novogorod Regional Clinical Hospital, Nizhniy Novgorod, Nizhniy Novgorod region, Russian Federation, 14.N N Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Minsk, Republic of Belarus, 15.Universidad de la Frontera, Temuco, Cautin, Republic of Chile, 16.First Department of Medicine - Department of Hematology, General University Hospital and Charles University in Prague, Prague, Czech Republic, 17.City of Hope, Duarte, Califonia, United States of America, 18.Comprehensive Cancer Center Ulm, Comprehensive Cancer Center Ulm, Ulm, Baden Wurttemberg, Federal Republic of Germany, 19.Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 20.Clinical Development Division, Celltrion, Inc., Incheon, Republic of Korea, 21.Toni Stephenson Lymphoma Center and Department of Hematology and Hematopoietic Cell Transplantation City of Hope, Duarte, Califonia, United States of America)